Thoughts from the Centre
A personal take on topical issues impacting the Healthcare and Life Sciences sector powered by Deloitte’s UK Centre for Health Solutions.
2025 outlook for US life sciences and health care: Consumers and convergence could disrupt the status quo
By Kulleni Gebreyes, M.D., vice chair and US Life Sciences & Health Care Industry leader, Deloitte
Our ten life sciences and healthcare predictions 2030 which we launched over the past five or so weeks explore the potential changes that the life science and healthcare sectors are likely to experience over the next five years. One of the key drivers for these changes is the need to address changing consumer expectations for more convenient, affordable, personalised care. Persistent long wait times and access and equity challenges highlight a growing disconnect between consumer needs and the services offered by traditional healthcare models. This week’s blog, which first appeared as a Center for Health Solution’s Health Forward blog, is by Deloitte’s new US Life Sciences and Health Care leader, Kulleni Gebreyes, M.D., explores how innovative life sciences and healthcare organisations could address these challenges through strategic cross-industry collaborations and convergence across different sectors and industries. While this blog is focused on the experience of US health care consumers, there are lessons for many other healthcare systems.
Accelerating the future: How to enable healthcare innovation, equity and sustainability
By Márcia Costa, Research Manager, and Emily May, Research Manager, Centre for Health Solutions
Last week, we published the last of our ten life sciences and healthcare (LSHC) predictions that together form our Accelerating the future vision. These predictions provide an optimistic and deliberately provocative view of the world in 2030 to help organisations prepare for the changes ahead. Realising this future, however, depends on overcoming four cross-cutting constraints that are impacting all ten predictions. Each constraint affects each prediction differently and requires new, innovative approaches to be tackled effectively. These constraints are not having the right: skills and talent, funding and business models, approach to regulation and governance over digitalisation and data. In this blog, we explore how to turn these constraints into enablers, to accelerate us towards the future outlined in our predictions.
Accelerating the future: driving growth and innovation through M&A and divestments
By Márcia Costa, Manager, and Karen Taylor, Director, Centre for Health Solutions
Our tenth and final prediction from our Accelerating the future: Life Sciences and Healthcare predictions 2030 report is on Life sciences mergers and acquisitions (M&A), divestments and restructuring. We anticipate that the uptick in M&A activity seen in 2024 will continue over the next five years and that by 2030 M&A will be a critical part of every life sciences company’s corporate strategy. Moreover, that divestments of non-core assets will be a critical element for every life sciences company, including pharma, consumer health and MedTech, in proactively managing their product portfolios, unlocking growth and embracing innovation. In this week’s blog, we summarise the insights from this prediction to help life sciences companies to rethink their M&A strategies up to 2030.
Accelerating the future: realising the potential of the Internet of Medical Things
By Márcia Costa, Manager, and Karen Taylor, Director, Deloitte Centre for Health Solutions
This week, we publish the penultimate prediction from our Accelerating the future: Life Sciences and Healthcare predictions 2030 report, Realising the potential of the Internet of Medical Things. As always, the prediction is intended to be both optimistic and provocative, this time looking into how MedTech companies might leverage advances in AI, cloud computing and connectivity to create data-driven innovations that enable more effective and personalised diagnoses, monitoring, and treatments for patients; and support the shift towards value-based healthcare. This week blog summarises the main insights from our MedTech prediction, how the constraints that could impede the prediction can be overcome and need to be over and explore how AI can help accelerate the prediction and the different roles that MedTech companies might play in the health ecosystem.
Accelerating the future: the transformations of health and wealth services and pharma’s commercial activities
By Emily May, Manager, and Márcia Costa, Manager, Centre for Health Solutions
This week we have published the seventh and eighth of our largely positive and optimistic global predictions from our Accelerating the future: Life Sciences and Healthcare predictions 2030 report, ‘The convergence of health, wealth and longevity services’ and the ‘End-to-end transformation of pharma’s commercial activities’. The seventh prediction explores how governments, employers, insurers and technology providers are collaborating to address the challenges of ageing and increasing dependency, and promoting longer, healthier and more economically active lives. The eight prediction focuses on the impact in 2030 of the digital transformation of the pharma commercial function, leveraging AI and data-driven insights to optimise commercial operations, enhance customer engagement and improve patient outcomes. Our blog this week highlights the key insights in these two predictions and what we can expect the world in 2030 to look and feel like.
Accelerating the future: pioneering a new era in pharma R&D and scientific and technological innovations
By Márcia Costa, Manager, and Emily May, Manager, Centre for Health Solutions
This week we have published the fifth and sixth predictions from our Accelerating the future: Life Sciences and Healthcare predictions 2030 report. These latest two predictions explore the Convergence of AI technologies and human expertise in pharma R&D and Interdependent innovations in science and technology are resharing treatment paradigms. Both consider what the world of medicine will look like in 2030. Our fifth prediction explores how end-to-end digitalisation, automation, and integration of AI technologies has transformed R&D, enabling quicker and more accurate decision-making in drug discover and significantly improved the productivity, efficiency and patient-centricity of clinical trials. The sixth prediction examines how innovative science and technologies that are available today, like quantum computing and AI, genomics and population health data profiles, have transformed the diagnostic and treatment paradigms. Our blog this week highlights the key insights in these two predictions.
Accelerating the future: towards Intelligent and sustainable healthcare
By Márcia Costa, Research Manager, and Emily May, Research Manager, Centre for Health Solutions
This week we have published the third and fourth predictions from our Accelerating the future: Life Sciences and Healthcare predictions 2030 report. While the first two predictions focused on the healthcare consumer and the consumer health industry, this second pair focus on developing more accessible, equitable, high quality, cost-effective and sustainable healthcare systems. Specifically, our third prediction assesses how the AI-enabled digitalisation of hospitals and other providers might help deliver the ambition for 5P (predictive, proactive, personalised, participatory and precise) healthcare; and our fourth prediction examines the healthcare system’s significant role in addressing the climate crisis. Our blog this week highlights the key insights in these two predictions: Intelligent Healthcare and the democratisation of health data; and Climate resilience and sustainable healthcare systems.
Health equity in Europe: A collective responsibility to act
Stephanie Delanbanque, Senior Consultant, Maria João Cruz, Manager, and Elizabeth Hampson, Partner
Although the World Health Organisation (WHO) declared health a fundamental human right in 1948, it is only in recent years, particularly since the COVID-19 pandemic, that there has been growing awareness of the health and economic impacts of health inequities within and between European countries. In response, the Deloitte Health Equity Institute (DHEI) has engaged 40 leaders across organisations in the European healthcare and life sciences ecosystem to explore their actions and attitudes towards health equity and what can be done to address current and future drivers of health inequity. Our blog this week shares the key findings from the Deloitte’s Health Equity Institute’s (DHEI) s first cross-European report, Health equity in Europe: a collective responsibility to act.
Accelerating the future: How consumer health companies are meeting the increased expectations of a more knowledgeable and empowered consumers
By Marcia Costa, Research Manager, and Emily May, Research Manager, Centre for Health Solutions
Technological advancements, acceleration in innovation and shifts in individuals’ expectations, are driving an unprecedented transformation in consumer health. Consumers are keen to improve their health literacy, enjoy equitable access and obtain personalised products and services; and the consumer health (CH) industry is energised by these changing expectations and has increased its focus on promoting wellbeing and extending healthy lifespans. This week we published the first two of ten predictions that inform our report ‘Accelerating the future: Life Sciences and Healthcare predictions 2030’. While our predictions are mostly optimistic and deliberately provocative, we acknowledge some of the constraints that need to be overcome to realise the prediction by 2030. This week’s blog explores the first two predictions: Consumers are the CEOs of their own health and The rise of a dynamic consumer health market.
Some healthtech investors are shifting from growth to value
By Adnan Qamar, consulting managing director, and Steve Gabster, senior manager, Deloitte Consulting LLP
Healthcare technology, or healthtech, is any technology, including medical devices, IT systems and software, algorithms, artificial intelligence (AI), cloud and blockchain, designed to support healthcare organisations.[1] These technologies are an integral part of modern healthcare. This week’s blog which first appeared as a Center for Health Solution’s Health Forward blog, shares insights from our US colleagues analysis of healthtech investment and market trends to identify the themes and patterns that are attracting healthtech investment. It explores the recent market trend towards quality and value alongside six priority areas for healthtech investors.